Additionally, in AD dementia and prodromal AD patients, the IP-MS approach measured elevated levels of CSF synaptosomal-associated protein 25 (SNAP-25) and synaptotagmin-1 (SYT1) [42]. Here, SYT1 is linked to Alzheimer disease.